IP Group

The business was founded in 2001 by David Norwood and Beeson Gregory as IP2IPO. It floated on the Alternative Investment Market in 2003 before achieving a full listing in 2006: it raised an additional £55m in June 2011. It acquired Top Technology Ventures in 2004, Techtran in January 2005, Fusion IP in March 2014 and Parkwalk Advisors, an EIS fund management business, in December 2016. IP Group then acquired Touchstone Innovations plc in 2017.

The origins of IP Group trace back to its first major university partnership with the University of Oxford. In December 2000, the business—then operating as IP2IPO—entered into a fifteen‑year agreement with the University of Oxford’s Chemistry Department under which IP2IPO acquired 50 per cent of the university’s equity and licensing income from chemistry‑related spin‑out companies. In return, IP2IPO committed substantial investment to support the department, including contributions towards the construction of new laboratory facilities.

The agreement was among the earliest large‑scale intellectual property commercialisation partnerships between a UK university department and an external investor, and it helped establish a model that IP Group later expanded to other universities and research institutions.

David Norwood stepped down from the business in 2008. Alan Aubrey became CEO in 2006 after the acquisition of Techtran before stepping down in 2021. Greg Smith, who was chief financial officer, became chief executive at that time, while David Baynes, chief operating officer, replaced Greg Smith as well as keeping his existing responsibility.

It was announced in January 2026 that Sir Douglas Flint, who was appointed as chair in 2018, would stand down in June 2026 to focus on his role at Prudential plc, following which Michael Queen, the former CEO of 3i Group plc, became chair.

IP Group operates as a long‑term investor in science and technology companies, providing capital and support from early‑stage formation through to later‑stage growth and exit. The group focuses on the commercialisation of intellectual property originating from universities and research institutions, particularly in the areas of deep technology, life sciences and clean technology.

The company invests both directly on its own balance sheet and through managed investment platforms, and typically takes a long‑term approach to portfolio development rather than operating as a traditional time‑limited venture capital fund.

IP Group develops and supports businesses in deep technology, life sciences and clean technology, and also backs innovation from universities and research institutions through funds managed by Parkwalk Advisors.

The company specialises in the commercialisation of university intellectual property rights.